MYELOMA

Incidence and Risk Factors...............1 2
Molecular Biology........................1 2
Cytogenetics - GEP.......................1 2
Clinical manifestations..................1 2 3
Extramedullary disease...................1
Amyloidosis..............................1 2

Bone disease: pathogenesis...............1
Bone disease: evaluation.................1 2
Bone disease: MRI........................1
Bone disease: PET........................1
Bone disease: pictures...................1 2 3

Laboratory findings......................1 2 3 4
Diagnosis................................1 2
Flow Cytometry...........................1

Staging - Response criteria..............1 2

Treatment: Corticosteroids...............1
Treatment: Chemotherapy..................1 2
Treatment: Thalidomide...................1 2 3
Treatment: Lenalidomide..................1 2
Treatment: Pomalidomide - other IMIDs....1
Treatment: Bortezomib....................1 2 3 4
Treatment: Carfilzomib - other PIs.......1
Treatment: Other.........................1 2

Autologous Transplant....................1 2 3 4
Tandem Transplants.......................1 2
Post-transplant maintenance..............1
Allogeneic Transplant....................1 2

Supportive therapy.......................1
Treatment of bone disease................1 2 3

Prognosis................................1 2

-------------------------------------------------------------------------------------------